UCB and Cancer Research UK partner for oncology antibody candidates

Preview

来源: Pharmaceutical Technology

The collaboration will focus on the development of UCB’s UCB6114 and UCB4594 investigational antibody candidates. Credit: Tatiana / Pixabay.

Preview

来源: Pharmaceutical Technology

Global biopharmaceutical firm UCB and Cancer Research UK have entered a multi-project partnership to advance two of the former’s oncology antibody candidates through clinical trials.

Free Whitepaper

PepSetsTM and their Applications

Peptide libraries are a powerful tool in biological research for screening large numbers of peptides in the search for the few, critical bioactive peptides.

Mimotopes PepSets are custom-synthesized peptide libraries supplied unpuried for fast, efcient screening work. These sets of chemically synthesized individual peptides are made

on a small scale using Mimotopes’ unique proprietary parallel array synthesis platform. PepSets comprising hundreds, or even thousands of peptides, are rapidly synthesized and shipped within a few weeks of ordering.

By Mimotopes Thematic

Preview

来源: Pharmaceutical Technology

Submit

Country Code

UK (+44)

USA (+1)

Algeria (+213)

Andorra (+376)

Angola (+244)

Anguilla (+1264)

Antigua & Barbuda (+1268)

Argentina (+54)

Armenia (+374)

Aruba (+297)

Australia (+61)

Austria (+43)

Azerbaijan (+994)

Bahamas (+1242)

Bahrain (+973)

Bangladesh (+880)

Barbados (+1246)

Belarus (+375)

Belgium (+32)

Belize (+501)

Benin (+229)

Bermuda (+1441)

Bhutan (+975)

Bolivia (+591)

Bosnia Herzegovina (+387)

Botswana (+267)

Brazil (+55)

Brunei (+673)

Bulgaria (+359)

Burkina Faso (+226)

Burundi (+257)

Cambodia (+855)

Cameroon (+237)

Canada (+1)

Cape Verde Islands (+238)

Cayman Islands (+1345)

Central African Republic (+236)

Chile (+56)

China (+86)

Colombia (+57)

Comoros (+269)

Congo (+242)

Cook Islands (+682)

Costa Rica (+506)

Croatia (+385)

Cuba (+53)

Cyprus North (+90392)

Cyprus South (+357)

Czech Republic (+42)

Denmark (+45)

Djibouti (+253)

Dominica (+1809)

Dominican Republic (+1809)

Ecuador (+593)

Egypt (+20)

El Salvador (+503)

Equatorial Guinea (+240)

Eritrea (+291)

Estonia (+372)

Ethiopia (+251)

Falkland Islands (+500)

Faroe Islands (+298)

Fiji (+679)

Finland (+358)

France (+33)

French Guiana (+594)

French Polynesia (+689)

Gabon (+241)

Gambia (+220)

Georgia (+7880)

Germany (+49)

Ghana (+233)

Gibraltar (+350)

Greece (+30)

Greenland (+299)

Grenada (+1473)

Guadeloupe (+590)

Guam (+671)

Guatemala (+502)

Guinea (+224)

Guinea - Bissau (+245)

Guyana (+592)

Haiti (+509)

Honduras (+504)

Hong Kong (+852)

Hungary (+36)

Iceland (+354)

India (+91)

Indonesia (+62)

Iran (+98)

Iraq (+964)

Ireland (+353)

Israel (+972)

Italy (+39)

Jamaica (+1876)

Japan (+81)

Jordan (+962)

Kazakhstan (+7)

Kenya (+254)

Kiribati (+686)

Korea North (+850)

Korea South (+82)

Kuwait (+965)

Kyrgyzstan (+996)

Laos (+856)

Latvia (+371)

Lebanon (+961)

Lesotho (+266)

Liberia (+231)

Libya (+218)

Liechtenstein (+417)

Lithuania (+370)

Luxembourg (+352)

Macao (+853)

Macedonia (+389)

Madagascar (+261)

Malawi (+265)

Malaysia (+60)

Maldives (+960)

Mali (+223)

Malta (+356)

Marshall Islands (+692)

Martinique (+596)

Mauritania (+222)

Mayotte (+269)

Mexico (+52)

Micronesia (+691)

Moldova (+373)

Monaco (+377)

Mongolia (+976)

Montserrat (+1664)

Morocco (+212)

Mozambique (+258)

Myanmar (+95)

Namibia (+264)

Nauru (+674)

Nepal (+977)

Netherlands (+31)

New Caledonia (+687)

New Zealand (+64)

Nicaragua (+505)

Niger (+227)

Nigeria (+234)

Niue (+683)

Norfolk Islands (+672)

Northern Marianas (+670)

Norway (+47)

Oman (+968)

Palau (+680)

Panama (+507)

Papua New Guinea (+675)

Paraguay (+595)

Peru (+51)

Philippines (+63)

Poland (+48)

Portugal (+351)

Puerto Rico (+1787)

Qatar (+974)

Reunion (+262)

Romania (+40)

Russia (+7)

Rwanda (+250)

San Marino (+378)

Sao Tome & Principe (+239)

Saudi Arabia (+966)

Senegal (+221)

Serbia (+381)

Seychelles (+248)

Sierra Leone (+232)

Singapore (+65)

Slovak Republic (+421)

Slovenia (+386)

Solomon Islands (+677)

Somalia (+252)

South Africa (+27)

Spain (+34)

Sri Lanka (+94)

St. Helena (+290)

St. Kitts (+1869)

St. Lucia (+1758)

Sudan (+249)

Suriname (+597)

Swaziland (+268)

Sweden (+46)

Switzerland (+41)

Syria (+963)

Taiwan (+886)

Tajikstan (+7)

Thailand (+66)

Togo (+228)

Tonga (+676)

Trinidad & Tobago (+1868)

Tunisia (+216)

Turkey (+90)

Turkmenistan (+7)

Turkmenistan (+993)

Turks & Caicos Islands (+1649)

Tuvalu (+688)

Uganda (+256)

UK (+44) -->

Ukraine (+380)

United Arab Emirates (+971)

Uruguay (+598)

USA (+1) -->

Uzbekistan (+7)

Vanuatu (+678)

Vatican City (+379)

Venezuela (+58)

Vietnam (+84)

Virgin Islands - British (+1284)

Virgin Islands - US (+1340)

Wallis & Futuna (+681)

Yemen (North)(+969)

Yemen (South)(+967)

Zambia (+260)

Zimbabwe (+263)

Country

UK

USA

Afghanistan

Åland Islands

Albania

Algeria

American Samoa

Andorra

Angola

Anguilla

Antarctica

Antigua and Barbuda

Argentina

Armenia

Aruba

Australia

Austria

Azerbaijan

Bahamas

Bahrain

Bangladesh

Barbados

Belarus

Belgium

Belize

Benin

Bermuda

Bhutan

Bolivia

Bonaire, Sint Eustatius and Saba

Bosnia and Herzegovina

Botswana

Bouvet Island

Brazil

British Indian Ocean Territory

Brunei Darussalam

Bulgaria

Burkina Faso

Burundi

Cambodia

Cameroon

Canada

Cape Verde

Cayman Islands

Central African Republic

Chad

Chile

China

Christmas Island

Cocos Islands

Colombia

Comoros

Congo

Democratic Republic of

the Congo

Cook Islands

Costa Rica

Côte d"Ivoire

Croatia

Cuba

Curaçao

Cyprus

Czech Republic

Denmark

Djibouti

Dominica

Dominican Republic

Ecuador

Egypt

El Salvador

Equatorial Guinea

Eritrea

Estonia

Ethiopia

Falkland Islands

Faroe Islands

Fiji

Finland

France

French Guiana

French Polynesia

French Southern Territories

Gabon

Gambia

Georgia

Germany

Ghana

Gibraltar

Greece

Greenland

Grenada

Guadeloupe

Guam

Guatemala

Guernsey

Guinea

Guinea-Bissau

Guyana

Haiti

Heard Island and McDonald Islands

Holy See

Honduras

Hong Kong

Hungary

Iceland

India

Indonesia

Iran

Iraq

Ireland

Isle of Man

Israel

Italy

Jamaica

Japan

Jersey

Jordan

Kazakhstan

Kenya

Kiribati

North Korea

South Korea

Kuwait

Kyrgyzstan

Lao

Latvia

Lebanon

Lesotho

Liberia

Libyan Arab Jamahiriya

Liechtenstein

Lithuania

Luxembourg

Macao

Macedonia, The Former

Yugoslav Republic of

Madagascar

Malawi

Malaysia

Maldives

Mali

Malta

Marshall Islands

Martinique

Mauritania

Mauritius

Mayotte

Mexico

Micronesia

Moldova

Monaco

Mongolia

Montenegro

Montserrat

Morocco

Mozambique

Myanmar

Namibia

Nauru

Nepal

Netherlands

New Caledonia

New Zealand

Nicaragua

Niger

Nigeria

Niue

Norfolk Island

Northern Mariana Islands

Norway

Oman

Pakistan

Palau

Palestinian Territory

Panama

Papua New Guinea

Paraguay

Peru

Philippines

Pitcairn

Poland

Portugal

Puerto Rico

Qatar

Réunion

Romania

Russian Federation

Rwanda

Saint Helena, Ascension and Tristan da Cunha

Saint Kitts and Nevis

Saint Lucia

Saint Pierre and Miquelon

Saint Vincent and The Grenadines

Samoa

San Marino

Sao Tome and Principe

Saudi Arabia

Senegal

Serbia

Seychelles

Sierra Leone

Singapore

Slovakia

Slovenia

Solomon Islands

Somalia

South Africa

South Georgia and The South

Sandwich Islands

Spain

Sri Lanka

Sudan

Suriname

Svalbard and Jan Mayen

Swaziland

Sweden

Switzerland

Syrian Arab Republic

Taiwan

Tajikistan

Tanzania

Thailand

Timor-Leste

Togo

Tokelau

Tonga

Trinidad and Tobago

Tunisia

Turkey

Turkmenistan

Turks and Caicos Islands

Tuvalu

Uganda

Ukraine

United Arab Emirates

US Minor Outlying Islands

Uruguay

Uzbekistan

Vanuatu

Venezuela

Vietnam

British Virgin Islands

US Virgin Islands

Wallis and Futuna

Western Sahara

Yemen

Zambia

Zimbabwe

Kosovo

-->

-->

-->

-->

-->

Submit

By clicking the Download Free Whitepaper button, you accept the terms and conditions and acknowledge that your data will be used as described in the Mimotopes Thematic privacy policy

By downloading this Whitepaper, you acknowledge that we may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our privacy policy for more information about our services, how we may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you.

Please check your email to download the Whitepaper.

The clinical development partnership will focus on the development of UCB6114 and UCB4594 investigational antibody candidates.

It will combine Cancer Research UK’s oncology-focused translational research and clinical development capabilities and the antibody discovery expertise of UCB.

If the clinical trials are successful, these candidates might have the potential to provide access to new targeted treatment options for cancer patients.

The potential first-in-class antibody UCB6114 targets a glycoprotein secreted by the tumour stroma, gremlin-1.

UCB4594 targets the immune checkpoint, human leukocyte antigen G, which is also called HLA-G.

Under the partnership, the Centre for Drug Development of Cancer Research UK will appoint the chief clinical and scientific investigators.

It will also lead the design, preparation, funding, and delivery of Phase I/II studies for both candidates, while UCB will continue their manufacturing.

UCB will also be responsible for completing the ongoing UCB6114 clinical study (ONC001) and performing other supporting works.

UCB chief scientific officer Dhaval Patel said: “UCB’s strong research productivity together with our antibody expertise and desire to better understand and target the drivers of disease, has resulted in two novel and potentially disruptive candidates in oncology.

“As these candidates move forward, we are happy to enter this collaboration with Cancer Research UK, where they will bring world-leading oncology expertise and access to a large network of clinical oncologists who can enable the clinical trials.”

The company will retain exclusive rights for further development and commercialisation of both candidates and obtain a licence for the clinical trial results from Cancer Research UK.

In return, UCB will make undisclosed success-based milestones and royalty payments to Cancer Research UK.

Early R&D projects coverage on Pharmaceutical Technology is supported by Mimotopes.

Editorial content is independently produced and follows the highest standards of journalistic integrity. Topic sponsors are not involved in the creation of editorial content.

Free Whitepaper

PepSetsTM and their Applications

Peptide libraries are a powerful tool in biological research for screening large numbers of peptides in the search for the few, critical bioactive peptides.

Mimotopes PepSets are custom-synthesized peptide libraries supplied unpuried for fast, efcient screening work. These sets of chemically synthesized individual peptides are made

on a small scale using Mimotopes’ unique proprietary parallel array synthesis platform. PepSets comprising hundreds, or even thousands of peptides, are rapidly synthesized and shipped within a few weeks of ordering.

By Mimotopes Thematic

Preview

来源: Pharmaceutical Technology

Submit

Country Code

UK (+44)

USA (+1)

Algeria (+213)

Andorra (+376)

Angola (+244)

Anguilla (+1264)

Antigua & Barbuda (+1268)

Argentina (+54)

Armenia (+374)

Aruba (+297)

Australia (+61)

Austria (+43)

Azerbaijan (+994)

Bahamas (+1242)

Bahrain (+973)

Bangladesh (+880)

Barbados (+1246)

Belarus (+375)

Belgium (+32)

Belize (+501)

Benin (+229)

Bermuda (+1441)

Bhutan (+975)

Bolivia (+591)

Bosnia Herzegovina (+387)

Botswana (+267)

Brazil (+55)

Brunei (+673)

Bulgaria (+359)

Burkina Faso (+226)

Burundi (+257)

Cambodia (+855)

Cameroon (+237)

Canada (+1)

Cape Verde Islands (+238)

Cayman Islands (+1345)

Central African Republic (+236)

Chile (+56)

China (+86)

Colombia (+57)

Comoros (+269)

Congo (+242)

Cook Islands (+682)

Costa Rica (+506)

Croatia (+385)

Cuba (+53)

Cyprus North (+90392)

Cyprus South (+357)

Czech Republic (+42)

Denmark (+45)

Djibouti (+253)

Dominica (+1809)

Dominican Republic (+1809)

Ecuador (+593)

Egypt (+20)

El Salvador (+503)

Equatorial Guinea (+240)

Eritrea (+291)

Estonia (+372)

Ethiopia (+251)

Falkland Islands (+500)

Faroe Islands (+298)

Fiji (+679)

Finland (+358)

France (+33)

French Guiana (+594)

French Polynesia (+689)

Gabon (+241)

Gambia (+220)

Georgia (+7880)

Germany (+49)

Ghana (+233)

Gibraltar (+350)

Greece (+30)

Greenland (+299)

Grenada (+1473)

Guadeloupe (+590)

Guam (+671)

Guatemala (+502)

Guinea (+224)

Guinea - Bissau (+245)

Guyana (+592)

Haiti (+509)

Honduras (+504)

Hong Kong (+852)

Hungary (+36)

Iceland (+354)

India (+91)

Indonesia (+62)

Iran (+98)

Iraq (+964)

Ireland (+353)

Israel (+972)

Italy (+39)

Jamaica (+1876)

Japan (+81)

Jordan (+962)

Kazakhstan (+7)

Kenya (+254)

Kiribati (+686)

Korea North (+850)

Korea South (+82)

Kuwait (+965)

Kyrgyzstan (+996)

Laos (+856)

Latvia (+371)

Lebanon (+961)

Lesotho (+266)

Liberia (+231)

Libya (+218)

Liechtenstein (+417)

Lithuania (+370)

Luxembourg (+352)

Macao (+853)

Macedonia (+389)

Madagascar (+261)

Malawi (+265)

Malaysia (+60)

Maldives (+960)

Mali (+223)

Malta (+356)

Marshall Islands (+692)

Martinique (+596)

Mauritania (+222)

Mayotte (+269)

Mexico (+52)

Micronesia (+691)

Moldova (+373)

Monaco (+377)

Mongolia (+976)

Montserrat (+1664)

Morocco (+212)

Mozambique (+258)

Myanmar (+95)

Namibia (+264)

Nauru (+674)

Nepal (+977)

Netherlands (+31)

New Caledonia (+687)

New Zealand (+64)

Nicaragua (+505)

Niger (+227)

Nigeria (+234)

Niue (+683)

Norfolk Islands (+672)

Northern Marianas (+670)

Norway (+47)

Oman (+968)

Palau (+680)

Panama (+507)

Papua New Guinea (+675)

Paraguay (+595)

Peru (+51)

Philippines (+63)

Poland (+48)

Portugal (+351)

Puerto Rico (+1787)

Qatar (+974)

Reunion (+262)

Romania (+40)

Russia (+7)

Rwanda (+250)

San Marino (+378)

Sao Tome & Principe (+239)

Saudi Arabia (+966)

Senegal (+221)

Serbia (+381)

Seychelles (+248)

Sierra Leone (+232)

Singapore (+65)

Slovak Republic (+421)

Slovenia (+386)

Solomon Islands (+677)

Somalia (+252)

South Africa (+27)

Spain (+34)

Sri Lanka (+94)

St. Helena (+290)

St. Kitts (+1869)

St. Lucia (+1758)

Sudan (+249)

Suriname (+597)

Swaziland (+268)

Sweden (+46)

Switzerland (+41)

Syria (+963)

Taiwan (+886)

Tajikstan (+7)

Thailand (+66)

Togo (+228)

Tonga (+676)

Trinidad & Tobago (+1868)

Tunisia (+216)

Turkey (+90)

Turkmenistan (+7)

Turkmenistan (+993)

Turks & Caicos Islands (+1649)

Tuvalu (+688)

Uganda (+256)

UK (+44) -->

Ukraine (+380)

United Arab Emirates (+971)

Uruguay (+598)

USA (+1) -->

Uzbekistan (+7)

Vanuatu (+678)

Vatican City (+379)

Venezuela (+58)

Vietnam (+84)

Virgin Islands - British (+1284)

Virgin Islands - US (+1340)

Wallis & Futuna (+681)

Yemen (North)(+969)

Yemen (South)(+967)

Zambia (+260)

Zimbabwe (+263)

Country

UK

USA

Afghanistan

Åland Islands

Albania

Algeria

American Samoa

Andorra

Angola

Anguilla

Antarctica

Antigua and Barbuda

Argentina

Armenia

Aruba

Australia

Austria

Azerbaijan

Bahamas

Bahrain

Bangladesh

Barbados

Belarus

Belgium

Belize

Benin

Bermuda

Bhutan

Bolivia

Bonaire, Sint Eustatius and Saba

Bosnia and Herzegovina

Botswana

Bouvet Island

Brazil

British Indian Ocean Territory

Brunei Darussalam

Bulgaria

Burkina Faso

Burundi

Cambodia

Cameroon

Canada

Cape Verde

Cayman Islands

Central African Republic

Chad

Chile

China

Christmas Island

Cocos Islands

Colombia

Comoros

Congo

Democratic Republic of

the Congo

Cook Islands

Costa Rica

Côte d"Ivoire

Croatia

Cuba

Curaçao

Cyprus

Czech Republic

Denmark

Djibouti

Dominica

Dominican Republic

Ecuador

Egypt

El Salvador

Equatorial Guinea

Eritrea

Estonia

Ethiopia

Falkland Islands

Faroe Islands

Fiji

Finland

France

French Guiana

French Polynesia

French Southern Territories

Gabon

Gambia

Georgia

Germany

Ghana

Gibraltar

Greece

Greenland

Grenada

Guadeloupe

Guam

Guatemala

Guernsey

Guinea

Guinea-Bissau

Guyana

Haiti

Heard Island and McDonald Islands

Holy See

Honduras

Hong Kong

Hungary

Iceland

India

Indonesia

Iran

Iraq

Ireland

Isle of Man

Israel

Italy

Jamaica

Japan

Jersey

Jordan

Kazakhstan

Kenya

Kiribati

North Korea

South Korea

Kuwait

Kyrgyzstan

Lao

Latvia

Lebanon

Lesotho

Liberia

Libyan Arab Jamahiriya

Liechtenstein

Lithuania

Luxembourg

Macao

Macedonia, The Former

Yugoslav Republic of

Madagascar

Malawi

Malaysia

Maldives

Mali

Malta

Marshall Islands

Martinique

Mauritania

Mauritius

Mayotte

Mexico

Micronesia

Moldova

Monaco

Mongolia

Montenegro

Montserrat

Morocco

Mozambique

Myanmar

Namibia

Nauru

Nepal

Netherlands

New Caledonia

New Zealand

Nicaragua

Niger

Nigeria

Niue

Norfolk Island

Northern Mariana Islands

Norway

Oman

Pakistan

Palau

Palestinian Territory

Panama

Papua New Guinea

Paraguay

Peru

Philippines

Pitcairn

Poland

Portugal

Puerto Rico

Qatar

Réunion

Romania

Russian Federation

Rwanda

Saint Helena, Ascension and Tristan da Cunha

Saint Kitts and Nevis

Saint Lucia

Saint Pierre and Miquelon

Saint Vincent and The Grenadines

Samoa

San Marino

Sao Tome and Principe

Saudi Arabia

Senegal

Serbia

Seychelles

Sierra Leone

Singapore

Slovakia

Slovenia

Solomon Islands

Somalia

South Africa

South Georgia and The South

Sandwich Islands

Spain

Sri Lanka

Sudan

Suriname

Svalbard and Jan Mayen

Swaziland

Sweden

Switzerland

Syrian Arab Republic

Taiwan

Tajikistan

Tanzania

Thailand

Timor-Leste

Togo

Tokelau

Tonga

Trinidad and Tobago

Tunisia

Turkey

Turkmenistan

Turks and Caicos Islands

Tuvalu

Uganda

Ukraine

United Arab Emirates

US Minor Outlying Islands

Uruguay

Uzbekistan

Vanuatu

Venezuela

Vietnam

British Virgin Islands

US Virgin Islands

Wallis and Futuna

Western Sahara

Yemen

Zambia

Zimbabwe

Kosovo

-->

-->

-->

-->

-->

Submit

By clicking the Download Free Whitepaper button, you accept the terms and conditions and acknowledge that your data will be used as described in the Mimotopes Thematic privacy policy

By downloading this Whitepaper, you acknowledge that we may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our privacy policy for more information about our services, how we may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you.

Please check your email to download the Whitepaper.

更多内容，请访问原始网站

文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。